Member Info for uinsionn

Larger pharmaceutical companies that utilize biological systems modeling in some of their R&D activities include Pfizer, AstraZeneca, Hoffman- La Roche, Johnson & Johnson Pharmaceutical Research Division, GlaxoSmithKline, Novartis, Organon, and Bayer. these all need our tech to speed up processes I wonder who our next major will be as per feb RNS its due soon

What is this actually worth to the big players well its going to save them billions of pounds in R&D, I would imagine at some stage we will get taken out as this tech is key to bigger players in inproving drugs to market and succes rate as well as on average reducing costs.Physiomics (AIM:PYC) is a computational systems biology services company applying simulations of cell behaviour to drug development to reduce the high attrition rates of clinical trials. 80-90 per cent of all clinical drug candidates fail to reach the market and estimates show that an overall ten per cent improvement in success rates could reduce the cost of one drug's development by as much as $242 million, from the current estimate of around $800 million1

For valuation comparison :- Oncimmune (ONC) Mkt Cap 77m Revenue 0.1m Physiomics (PYC) Mkt Cap 3.8m Revenue 0.7m and rising plus pyc have been able to keep their burn rate to a minimum through good controls and the continued support of government grants, which when they apply the project gets accesses for future and how it is growing and performing. these grants are given to companies that have tech that can change the way things evolve.

AIM gets a lot of stick, and quite rightly sometimes, for incubating some quite dreadfully run businesses that tend to be pumped and dumped. But every once in a while it comes up with a gem and Physiomics is a case in point. What it has developed could save lives. For the Oxford-based groups VT technology is able to model the combined effects of different cancer treatments at a cellular level. Its work with Merck showed it was also able to scale up the results to allow meaningful predictions of overall tumour growth that provided 'valuable insights'. Press coverage for PYC #GEM

they are doing a market update very soon according to previous RNS, another major taken a project to them waiting for the update on that, but it is undervalued at current level anyway compared to similar tech in the market place that has no revenues, expect new major tech sponsor to drive this nuts with merck already onboard a second huge major here and boom, let the majors fight it out over the tech, this will get taken out this year

Key events subsequent to the period include: � Announcement of a pre-clinical project with a new major pharmaceutical client, due to complete during current financial year� Announcement of a pre-clinical project with a third major (global top-10) pharmaceutical client in a matter of months. We should see another major come on board very soon and with lots of meeting set up this is about to move heavy with new contracts and interest from other pharmas

is a great investment for 2018 why * Revenue generating company * Focused strategy and route to market * Very small FF * Excellent BOD and shareholder list * Worldwide focus, already building a strong brand * links to one of the worlds biggest brands LEGO * 60 events already confirmed * looking to open 100 cafes in china * China will open a second permanent BRICKLIVE centre * Following the signing of its first two centres in China, LVCG is planning to debut up to a further three later this year and then five more each year thereafter. * following LVCG's successful show in New York in February 2018, the Company has decided, to launch the BRICKLIVE brand across the US and to discontinue the LEGO LIVE brand

#LVCG great thing about this company is there are plenty of outlets for following http://livecompanygroup.com/index.html website http://livecompanygroup.com/blog1.html blog @LVCGplc active twitter feed http://bricklive.co.uk/?gclid=Cj0KCQjwtZzWBRD2ARIsAIPenY0BKh8BXzvX45opJqsi2DS7iR7A13fyF7m0MdCnFXPtZHfJH_3UFvgaAhCMEALw_wcB � bricklive http://www.lse.co.uk/share-regulatory-news.asp?shareprice=LVCG&ArticleCode=7ax167kh&ArticleHeadline=Company_update � latest RNS plenty of ways of watching growth

this company is going to be huge over the coming year, they are now rolling out cafes and have agreements for permanent venues too, all we need now is some update on revenues being made and we are away, looks very sticky at these level, strong holders in this one and once the market wakes up to the potential here it will fly from here.

LVCG is pleased to announce that Bricklive International Limited ("BLI"), a subsidiary of the newly acquired Bricklive Group Limited has today entered into a six-year contract with Universal Entretenimento e Produ��es LTDA ("UEP") for BRICKLIVE events in Brazil. The contract provides a guaranteed 30 events every 15 months (a "Period"), which will increase the number of contracted BRICKLIVE events in 2018 to approximately 60, twice the number of shows previously contracted for the year.

have been topping up here the last few weeks, this is looking very tight at this level and FF is low, expecting an update very soon which will have us well over previous highs

The Loan Notes will not bear interest. In certain events of default by the Company or the Company not having sufficient share authorities in place to permit the issue of Ordinary Shares on a conversion of the Loan Notes, the Investor may elect to redeem the Loan Notes for 120 per cent. of the par value of such Loan Notes. In the event of a change of control of the Company, the Company may be required to redeem the Loan Notes at 110 per cent. of the par value of such Loan Notes. The Company can also elect to redeem at any time one or more Loan Notes at a price equal to 105 per cent. of the par value of such Loan Notes, subject to giving the Investor 10 business days' notice, following which the Investor will have the ability to convert some or all of these Loan Notes instead.

AT what price was the conversion done, that's the question, when it was cancelled average for 10 days plus 25%

EQTEC plc (AIM: EQT), the technology solution company for waste gasification to energy projects, announces that further to the statement of 28 February 2018, the Board of Directors has decided not to proceed with any further draw down amounts under the Unsecured Convertible Loan Note Facility Agreement of up to �7.5 million ("Loan Notes"). In addition, the Company has agreed in principle, and is in preliminary discussions with the investor and the Company's advisers, to cancel the Loan Note Agreement, and for the redemption of existing amounts outstanding at the earliest opportunity.

the company must issue shares, if the company refuse to issue shares where does he stand, if they repay the 1.5m and 300k cancellation fee,

didnt look back at you posts, but as of yet he has not converted

Mr. Betolaza (Managing Partner Black Toro Capital) serves on the board of Teesside Gas Processing Plant Limited. "The Teesside Gas Processing Plant (TGPP) is located at SEAL SANDS on Teesside in northeast England." TGPP is with natural gas from North Sea but he will know the area and know Eqtec's proposed involvement in Reliable Seal Sands.

You will probably find the talks between the Company and the lender have broken down and the lender is now sitting on a large short position trying to get paid out at these levels and the Company saying 'No'. if the company are able to pay back the loan then there will be fun in the markets as the lender will not be able to cover in the market..the SP will shift up too quickly. I suspect the Company know this and feel in the driving seat somewhat.

good, getting hard to pick up anything on volume now, glad i have been buying the last week or so,

looks like people seeing value down here, a couple of good buys coming in